INSIGHT 2021
September 9-12
From Science to Implementation
INSIGHT 2021 provided the space for an enriching and respectful dialogue between psychedelic researchers, practitioners, leading experts from the psychedelic industry, and the interested public. For the first time, the conference not only took place in Berlin, but was also live-streamed into the world.
More than 1300 people attended in person and online.
Based on the feedback from INSIGHT 2019 attendees, we offered even more panel discussions and opportunities for audience participation. These formats allowed for the incorporation of diverse perspectives and controversial opinions. Particularly, INSIGHT 2021 discussed many ethical questions about integrating and implementing altered states of consciousness in the health care system and wider society.
The conference presentations were organized into four tracks, allowing for a multidisciplinary and practical approach that constituted the INSIGHT 2021 motto: From Science to Implementation.
1. Treatment (with the sub-tracks Integration Therapy and Ketamine-assisted therapy)
2. Basic Research
3. Public Health (with the sub-tracks: Anthropology, History, Non-pharmacological methods, Political Regulation and Self Development)
4. Implementation (with the sub-tracks: psychedelic industry, philosophy, and ethics of psychedelic states)
Gallery
View more Images
Some video impressions from INSIGHT
INSIGHT 2021 Recordings - Available on the MIND Community Platform
All INSIGHT 2021 ticketholders and MIND members get free access to all recordings. Please login to your your Members Dashboard and find the link to the recordings there.
Prof. Dr. Davit Nutt - Developing the Current Status of Psychedelics in Psychiatry
Dr. Sandeep Nayak - Belief changes following a single psychedelic experience: Results of a survey study
Dr. Paul Liknaitzky - Old medicines, new misunderstandings
INSIGHT 2021 speakers
Prof. Dr. med. Gerhard Gründer
Department of Molecular Neuroimaging, Central Institute of Mental Health Mannheim
Prof. Dr. med. Franz X. Vollenweider
University of Zürich
Dr. Katrin Preller
University of Zürich and Yale University
Prof. Dr. Matthew Johnson
Johns Hopkins University School of Medicine
Prof. Dr. David Nutt
Imperial College London, Division of Brain Sciences
Dr. sc. hum. Henrik Jungaberle
MIND Foundation
Gül Dölen, M.D., Ph.D.
Johns Hopkins University
Prof. Dr. Matthias Liechti
University Hospital, Basel
Dr. med. Peter Gasser
Swiss Medical Society for Psycholytic Therapy
Prof. Stephen Asma
Columbia College Chicago
Dr. med. Andrea Jungaberle
MIND Foundation and OVID Health Systems
David Bronner
Dr. Bronner’s
Rick Doblin, Ph.D.
Multidisciplinary Association for Psychedelic Studies (MAPS)
Charles Raison, M.D.
University of Wisconsin, Usona Institute, & Emory Healthcare
Prof. Dr. Harry Sumnall
Public Health Institute of the Liverpool John Moores University, United Kingdom
Dr. Martha Havenith
Ernst-Strüngmann Institute for Neuroscience
Prof. Dr. Stefan Borgwardt
University Hospital Schleswig-Holstein
Prof. Dr. Dr. Uwe Herwig
Center for Psychiatry Reichenau, Academic Teaching Hospital of the University of Konstanz
Viktor Chvatal
PsychedelicsEUROPE
Dr. Ben Sessa
Chief Medical Officer at Awakn Life Sciences
Neşe Devenot, PhD
Medicine, Society & Culture Research Fellow at Psymposia
Mendel Kaelen, Ph.D.
Wavepaths
Dr. Chris Letheby
University of Western Australia & University of Adelaide
Dr. Manvir Singh
Institute for Advanced Study in Toulouse
Dr. med. Marion Haberkamp
Federal Institute of Drugs and Medical Devices, Germany
Tomas Palenicek, PhD
National Institute of Mental Health, Czech Republic
Dr. Ingmar Gorman
Fluence
Amy Emerson
MAPS Public Benefit Corporation
John Schneider, Ph.D.
Avalon Health Economics
Keren Tzarfaty, Ph.D., MFT
MAPS Israel
Dr. Elizabeth Nielson
Columbia University Irving Medical Center and New York State Psychiatric Institute (NYSPI)
Prof. Dr. Dimitri van der Linden
Erasmus University Rotterdam
Elliot Marseille, DrPH, MPP
University of California, Berkeley
Dr. Anna Ciaunica
University of Porto, University College London
Srinivas Rao, MD, PhD
atai Life Sciences
Enzo Tagliazucchi, Ph.D.
University of Buenos Aires
Vanja Palmers
Kloster Felsentor
Federico Zamberlan
Computational Cognitive Neuroscience Laboratory; Departamento de Física, Universidad de Buenos Aires; Instituto de Física de Buenos Aires (IFIBA); National Scientific and Technical Research Council (CONICET), Argentina
Maartje Nevejan
Independent Film director
Annette Badenhorst
Co-Producer
Dr. med. Ansgar Rougemont-Bücking
University of Fribourg, Switzerland
Tura Patterson, M.A.
Usona Institute
Dr. rer. nat. Max Wolff
MIND Foundation
Dr. Sandeep Nayak, M.D.
Johns Hopkins University
Julia Bornemann
Centre for Psychedelic Research at Imperial College London
Rebecca Harding, BSc
Master’s Student Centre for Psychedelic Research, Imperial College London
Tommaso Barba, M.Sc.
Centre of Psychedelic Research, Imperial College London
Rayyan Zafar, BSc. MSc.
Department of Brain Sciences, Imperial College London
Christopher Timmermann, Ph.D.
Centre for Psychedelic Research, Imperial College London
Daan Frans Oostveen, Ph.D.
Institute for Culture Inquiry at Utrecht University
Lea Mertens, M.Sc.
Central Institute of Mental Health Mannheim
Marcus Meinhardt, Ph.D.
Central Institute of Mental Health Mannheim
Dr. Mihai Avram
Schleswig Holstein University Hospital University Lübeck
Ulf Bremberg, PhD.
Osmond Labs
Helena Rogg, M.D.
Department of Psychiatry and Psychotherapy, Schleswig‐Holstein University Hospital, University Lübeck
Paul Liknaitzky, Ph.D.
Turner Institute (School of Psychological Sciences) and Dept of Psychiatry (School of Clinical Sciences), Monash University
Urszula Kozlowska, Ph.D.
Institute of Bioorganic Chemistry Polish Academy of Sciences
Samuli Kangaslampi, Ph.D.
Tampere University
Sergio Pérez Rosal, M.D.
MIND Foundation
Dr. Kelan Thomas
Touro University California College of Pharmacy
Dr. rer. nat. Barbara Breitenstein, Dipl.-Psych.
OVID Health Systems
Pedro J. Teixeira, Ph.D.
University of Lisbon | Faculty of Human Kinetics
PD Dr. Kurt Stocker
ETH Swiss Federal Institute of Technology Zurich
Marvin Däumichen, M.A.
MIND Foundation
Dr. Regina Hess
MIND Foundation
Dr. Timo Torsten Schmidt
Freie Universität Berlin
Dr. Alan Davis
Ohio State University / Johns Hopkins University / Source Research Foundation
Dr. David Glowacki
CiTIUS Intelligent Technologies Research Centre
Friederike Holze, Ph.D.
University Hospital Basel and University of Basel
Arne Harms, Dr. Phil.
Max Planck Institute for Social Anthropology, Halle, Germany
Dipl.-Psych. Max Leidenberger
OVID Health Systems
Rebecca Rothberg, Psy.D.
PGSP-Stanford Psy.D. Consortium
Dr. Sam Dunscombe
Monash University
Isabel Wießner, M.Sc.
University of Campinas
Paloma David, RMA
Amsterdam Psychedelic Research Association
Danny Forde, M.Phil.
University College Cork
Benjamin Spahr, M.D.
Department for Anaesthesiology and Intense Care of Klinikum Neukölln
Dr. Fabian Wenner
MIND Foundation / Federal Ministry of Health
Dr. rer. medic. Laura F. Kuhle
Charité – Universitätsmedizin Berlin and OVID Health Systems
Ludovica Sacchi, M.A.
Leipzig Universität
Ozan Polat
Vine Ventures
Anna Becker, M.Sc.
University of Basel
Rob Coffey, M.Sc./MIACP
Inwardbound Retreats
Henry Whitfield, M.Sc. (CBT/REBT) MBACP
Regents University London - Regents School of Psychology and Psychotherapy
Aurora Savino, M.Phil.
Università di Torino
Maria Amato, M.Sc.
Synthesis Retreat
Marco Schlosser, M.Sc.
Division of Psychiatry, University College London
Stefan Lang, M.A.
Zentrum für Buddhismus, Bern
Johan Planefeldt, B.A.
VANI Studio
Eugen Secară, M.Sc.
University of Vienna & Babeș-Bolyai University
Jonas Di Gregorio, B.A.
Psychedelic Literacy Fund
David Heuer, M.A.
MIND Foundation
Dr. Felix Blei
Projekt Miraculix
Amelia Young, M.Sc.
EDGE Neuroscience & Art e.V.
Tatiana Lupashina, M.Sc.
EDGE Neuroscience & Art e.V.
Floris Wolswijk, M.Sc.
Coaching & Psychedelics Section´s Speaker
Patrick Wentorp, B.A.
MIND Foundation
Camile Bahi, M.Pharm.
MIND Foundation
Felix Uhl, B.A.
Goethe University in Frankfurt am Main
Alina Ruge, B.Sc.
Institute for Neurocognitive Psychology at University Oldenburg
Michael V. Kramer
Duquesne University
Drummond McCulloch, B.Sc.
Neurobiology Research Unit, Copenhagen University Hospital
Ivan Skorodumov, M.Sc.
Central Institute of Mental Health, Mannheim
Laura Kärtner, M.Sc.
Zentralinstitut für seelische Gesundheit ﴾ZI Mannheim﴿
Dr. med. Sebastian Gaus
OVID Practice
Lena Lindström, M.Sc.
Lund University
Iga Adamska
Centre for Modern Interdisciplinary Technologies, Nicolaus Copernicus University in Toruń
Celine Winter
University of Madgeburg
Lisa Luan, M.Sc.
Imperial College London
Lukas Basedow, M.Sc.
TU Dresden
Merve Akan, B.Sc.
Bogazici University ‐ Department of Psychology, Behavioral Neuroscience Laboratory
Marc Rozenkranz
University of Oldenburg
Soma Makai-Bölöni, M.Sc.
Centre for Human Drug Research ﴾CHDR﴿, Leiden
Torben Ott, Ph.D.
Washington University in Saint Louis
Hannah Douglass, M.Sc.
Centre for Psychedelic Research, Imperial College London
Ada Kaluzna B.Sc.
University College London
Baiba Baika, M.A.
Consciousness Medicine Foundation Latvia
Dimitri Daldegan-Bueno, M.Sc.
Schools of Population Health and Pharmacy, Faculty of Medical and Health Sciences, University of Auckland
George Fejer, M.Sc.
University of Amsterdam
Helena Aicher, M.Sc.
Psychedelic Research & Therapy Development, University Hospital of Psychiatry, University of Zurich
Ioana Ivan, Mrd.
Babeș‐Bolyai University, Faculty of Psychology and Educational Sciences
Karolina Kolaczynska, M.Sc.
University of Basel
Lasse Damgaard, M.Sc.
Aarhus University
Dr. Paul Soons
GGZ groep
Dr. med. Umberto Pannacci
Unit of Child Neurology and Psychiatry of University of Bologna, Italian Study Group for Psychedelic Research
Jitka Nykodemová, M.Sc.
University of Copenhagen / University of Chemistry and Technology Prague
Anastasia Ruban, M.Sc.
SWPS University of Social Sciences and Humanities, Department of Psychology, Warsaw
Anna Schibli, B.Sc.
University of Fribourg
Frederico Cavanna, LPsy
University of Buenos Aires
Joseph Rootman, M.A.
University of British Columbia
Jonas Neubert, B.A.
Maastricht University
Justyna Holka-Pokoska, MD PhD FECSM
Institute of Psychiatry and Neurology Warsaw
Luan van Pletsen, M.Eng.
Imperial College London
Mauro Cavarra, M.Sc.
University of Messina, University of Maastricht
Mateo Sanchez Petrement, RMa
University of Amsterdam
View all speakers
Workshops
Introduction to BEYOND Experience - The MIND Foundation Integration Program
David Heuer, M.A.
Augmented Psychotherapy Training Workshop
Dr. rer. nat. Max Wolff
Sonic Arts Practice and Psychedelia: How the Theory and Practice of Experimental Music might Speak to the Psychedelic Experience
Dr. Sam Dunscombe, Julia Reidy
Ketamine-augmented psychotherapy for depression (KAP) – A treatment approach for outpatient practice.
Dipl.-Psych. Max Leidenberger, Dr. rer. medic. Laura F. Kuhle, Dr. rer. nat. Barbara Breitenstein, Dipl.-Psych.
Molecules: A Hands-On Workshop for Emergency Prevention & Management
Benjamin Spahr, M.D., Sergio Pérez Rosal, M.D., Dr. Felix Blei
uniMIND Workshop – Build community, exchange knowledge, facilitate research
Marvin Däumichen, M.A.
Psychedelic-Assisted Somatic Therapy – Practice-Oriented Workshop
Dr. Regina Hess, Keren Tzarfaty, Ph.D., MFT
Ketamin-augmentierte Psychotherapie bei Depression (KAP) – Ein Behandlungsansatz für die Ambulante Praxis
Dipl.-Psych. Max Leidenberger, Dr. rer. medic. Laura F. Kuhle, Dr. rer. nat. Barbara Breitenstein, Dipl.-Psych.
Coaching & Psychedelics: Annealing the Creative Mind
Floris Wolswijk, M.Sc.
Psychedelic Experiences as Invitations to Philosophical Questions
Felix Uhl, M.A., Michael Kramer, M.A.
MHS - A Growing Network of Psychedelic Therapists and Co-Therapists
Dr. Max Wolff, Eugen Secara, M.Sc.
Advances in Neuroscience
Camile Bahi, M.Pharm, Celine Winter, B.A., Marc Rosenkranz, B.A., Alina Ruge, B.Sc.
Flow States: The creative journey & Psychedelics
Tatiana Lupashina, M.Sc., Amelia Young, M.Sc.
Legal and Ethical Considerations in Psychedelic Research
Dr. jur. Fabian Wenner